|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Duarte I and Llanos O: Patterns of
metastases in intestinal and diffuse types of carcinoma of the
stomach. Hum Pathol. 12:237–242. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yokota T, Teshima S, Saito T, Kikuchi S,
Kunii Y and Yamauchi H: Borrmanns type IV gastric cancer:
Clinicopathologic analysis. Can J Surg. 42:371–376. 1999.PubMed/NCBI
|
|
4
|
Yasui W, Kuniyasu H, Akama Y, Kitahara K,
Nagafuchi A, Ishihara S, Tsukita S and Tahara E: Expression of
e-cadherin, alpha-catenins and Beta-catenins in human gastric
carcinomas - correlation with histology and tumor progression.
Oncol Rep. 2:111–117. 1995.PubMed/NCBI
|
|
5
|
Hippo Y, Yashiro M, Ishii M, Taniguchi H,
Tsutsumi S, Hirakawa K, Kodama T and Aburatani H: Differential gene
expression profiles of scirrhous gastric cancer cells with high
metastatic potential to peritoneum or lymph nodes. Cancer Res.
61:889–895. 2001.PubMed/NCBI
|
|
6
|
Matsubara D, Kishaba Y, Yoshimoto T,
Sakuma Y, Sakatani T, Tamura T, Endo S, Sugiyama Y, Murakami Y and
Niki T: Immunohistochemical analysis of the expression of
E-cadherin and ZEB1 in non-small cell lung cancer. Pathol Int.
64:560–568. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Romero-Pérez L, López-García MÁ,
Díaz-Martín J, Biscuola M, Castilla MÁ, Tafe LJ, Garg K, Oliva E,
Matias-Guiu X, Soslow RA, et al: ZEB1 overexpression associated
with E-cadherin and microRNA-200 downregulation is characteristic
of undifferentiated endometrial carcinoma. Mod Pathol.
26:1514–1524. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Burk U, Schubert J, Wellner U, Schmalhofer
O, Vincan E, Spaderna S and Brabletz T: A reciprocal repression
between ZEB1 and members of the miR-200 family promotes EMT and
invasion in cancer cells. EMBO Rep. 9:582–589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Poliseno L, Salmena L, Riccardi L, Fornari
A, Song MS, Hobbs RM, Sportoletti P, Varmeh S, Egia A, Fedele G, et
al: Identification of the miR-106b~25 microRNA cluster as a
proto-oncogenic PTEN-targeting intron that cooperates with its host
gene MCM7 in transformation. Sci Signal. 3:ra292010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sethi S, Kong D, Land S, Dyson G, Sakr WA
and Sarkar FH: Comprehensive molecular oncogenomic profiling and
miRNA analysis of prostate cancer. Am J Transl Res. 5:200–211.
2013.PubMed/NCBI
|
|
11
|
Hassan O, Ahmad A, Sethi S and Sarkar FH:
Recent updates on the role of microRNAs in prostate cancer. J
Hematol Oncol. 5:92012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Landgraf P, Rusu M, Sheridan R, Sewer A,
Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M,
et al: A mammalian microRNA expression atlas based on small RNA
library sequencing. Cell. 129:1401–1414. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ventura A and Jacks T: MicroRNAs and
cancer: Short RNAs go a long way. Cell. 136:586–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bojmar L, Karlsson E, Ellegård S, Olsson
H, Björnsson B, Hallböök O, Larsson M, Stål O and Sandström P: The
role of microRNA-200 in progression of human colorectal and breast
cancer. PLoS One. 8:e848152013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ceppi P, Mudduluru G, Kumarswamy R, Rapa
I, Scagliotti GV, Papotti M and Allgayer H: Loss of miR-200c
expression induces an aggressive, invasive, and chemoresistant
phenotype in non-small cell lung cancer. Mol Cancer Res.
8:1207–1216. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu J, Ohuchida K, Mizumoto K, Sato N,
Kayashima T, Fujita H, Nakata K and Tanaka M: MicroRNA,
hsa-miR-200c, is an independent prognostic factor in pancreatic
cancer and its upregulation inhibits pancreatic cancer invasion but
increases cell proliferation. Mol Cancer. 9:1692010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Marchini S, Cavalieri D, Fruscio R, Calura
E, Garavaglia D, Nerini I Fuso, Mangioni C, Cattoretti G, Clivio L,
Beltrame L, et al: Association between miR-200c and the survival of
patients with stage I epithelial ovarian cancer: A retrospective
study of two independent tumour tissue collections. Lancet Oncol.
12:273–285. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kurashige J, Mima K, Sawada G, Takahashi
Y, Eguchi H, Sugimachi K, Mori M, Yanagihara K, Yashiro M, Hirakawa
K, et al: Epigenetic modulation and repression of miR-200b by
cancer-associated fibroblasts contribute to cancer invasion and
peritoneal dissemination in gastric cancer. Carcinogenesis.
36:133–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shinozaki A, Sakatani T, Ushiku T, Hino R,
Isogai M, Ishikawa S, Uozaki H, Takada K and Fukayama M:
Downregulation of microRNA-200 in EBV-associated gastric carcinoma.
Cancer Res. 70:4719–4727. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song F, Yang D, Liu B, Guo Y, Zheng H, Li
L, Wang T, Yu J, Zhao Y, Niu R, et al: Integrated microRNA network
analyses identify a poor-prognosis subtype of gastric cancer
characterized by the miR-200 family. Clin Cancer Res. 20:878–889.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou X, Wang Y, Shan B, Han J, Zhu H, Lv
Y, Fan X, Sang M, Liu XD and Liu W: The downregulation of
miR-200c/141 promotes ZEB1/2 expression and gastric cancer
progression. Med Oncol. 32:4282015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Akagi T and Kimoto T: Human cell line
(HGC-27) derived from the metastatic lymph node of gastric cancer.
Acta Med Okayama. 30:215–219. 1976.PubMed/NCBI
|
|
23
|
Akiyama S, Amo H, Watanabe T, Matsuyama M,
Sakamoto J, Imaizumi M, Ichihashi H, Kondo T and Takagi H:
Characteristics of three human gastric cancer cell lines, NU-GC-2,
NU-GC-3 and NU-GC-4. Jpn J Surg. 18:438–446. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kakinuma N, Sato M, Yamada T, Kohu K,
Nakajima M, Akiyama T, Ohwada S and Shibanaka Y: Cloning of novel
LERGU mRNAs in GPR30 3 untranslated region and detection of 2
bp-deletion polymorphism in gastric cancer. Cancer Sci. 96:191–196.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Motoyama T, Hojo H and Watanabe H:
Comparison of seven cell lines derived from human gastric
carcinomas. Acta Pathol Jpn. 36:65–83. 1986.PubMed/NCBI
|
|
26
|
Konno-Shimizu M, Yamamichi N, Inada K,
Kageyama-Yahara N, Shiogama K, Takahashi Y, Asada-Hirayama I,
Yamamichi-Nishina M, Nakayama C, Ono S, et al: Cathepsin E is a
marker of gastric differentiation and signet-ring cell carcinoma of
stomach: A novel suggestion on gastric tumorigenesis. PLoS One.
8:e567662013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yamada Y, Yoshida T, Hayashi K, Sekiya T,
Yokota J, Hirohashi S, Nakatani K, Nakano H, Sugimura T and Terada
M: p53 gene mutations in gastric cancer metastases and in gastric
cancer cell lines derived from metastases. Cancer Res.
51:5800–5805. 1991.PubMed/NCBI
|
|
28
|
Tanaka M, Oikawa K, Takanashi M, Kudo M,
Ohyashiki J, Ohyashiki K and Kuroda M: Down-regulation of miR-92 in
human plasma is a novel marker for acute leukemia patients. PLoS
One. 4:e55322009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu W, Takanashi M, Borjigin N, Ohno SI,
Fujita K, Hoshino S, Osaka Y, Tsuchida A and Kuroda M: MicroRNA-18a
modulates STAT3 activity through negative regulation of PIAS3
during gastric adenocarcinogenesis. Br J Cancer. 108:653–661. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Acs G, Zhang PJ, McGrath CM, Acs P,
McBroom J, Mohyeldin A, Liu S, Lu H and Verma A: Hypoxia-inducible
erythropoietin signaling in squamous dysplasia and squamous cell
carcinoma of the uterine cervix and its potential role in cervical
carcinogenesis and tumor progression. Am J Pathol. 162:1789–1806.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chang L, Guo F, Huo B, Lv Y, Wang Y and
Liu W: Expression and clinical significance of the microRNA-200
family in gastric cancer. Oncol Lett. 9:2317–2324. 2015.PubMed/NCBI
|
|
32
|
Tamura G, Sakata K, Nishizuka S, Maesawa
C, Suzuki Y, Iwaya T, Terashima M, Saito K and Satodate R:
Inactivation of the E-cadherin gene in primary gastric carcinomas
and gastric carcinoma cell lines. Jpn J Cancer Res. 87:1153–1159.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Murai T, Yamada S, Fuchs BC, Fujii T,
Nakayama G, Sugimoto H, Koike M, Fujiwara M, Tanabe KK and Kodera
Y: Epithelial-to-mesenchymal transition predicts prognosis in
clinical gastric cancer. J Surg Oncol. 109:684–689. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Elson-Schwab I, Lorentzen A and Marshall
CJ: MicroRNA-200 family members differentially regulate
morphological plasticity and mode of melanoma cell invasion. PLoS
One. 5:e131762010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Doki Y, Shiozaki H, Tahara H, Inoue M, Oka
H, Iihara K, Kadowaki T, Takeichi M and Mori T: Correlation between
E-cadherin expression and invasiveness in vitro in a human
esophageal cancer cell line. Cancer Res. 53:3421–3426.
1993.PubMed/NCBI
|
|
36
|
Ji M, Lee EJ, Kim KB, Kim Y, Sung R, Lee
SJ, Kim DS and Park SM: HDAC inhibitors induce
epithelial-mesenchymal transition in colon carcinoma cells. Oncol
Rep. 33:2299–2308. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Takeichi M: The cadherins: Cell-cell
adhesion molecules controlling animal morphogenesis. Development.
102:639–655. 1988.PubMed/NCBI
|
|
38
|
Castilla MÁ, Moreno-Bueno G, Romero-Pérez
L, Van De Vijver K, Biscuola M, López-García MÁ, Prat J,
Matías-Guiu X, Cano A, Oliva E, et al: Micro-RNA signature of the
epithelial-mesenchymal transition in endometrial carcinosarcoma. J
Pathol. 223:72–80. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shao Y, Geng Y, Gu W, Huang J, Pei H and
Jiang J: Prognostic role of tissue and circulating microRNA-200c in
malignant tumors: A systematic review and meta-analysis. Cell
Physiol Biochem. 35:1188–1200. 2015. View Article : Google Scholar : PubMed/NCBI
|
